PIQUE, INC. – Trademark Portfolio
Entity Type: 03
PIQUE, INC. owns a portfolio of 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as PIQUE, NANDAKA, LA GINGER, B· T FOUNTAIN, and DAILY RADIANCE. Of these, 12 are registered. The portfolio spans 4 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 30 (Staple Foods). Headquartered in LOS ANGELES, CA.
11693 SAN VICENTE BLVD., #900
LOS ANGELES, CA 90049
Showing of trademarks Trademarks
Trademark Classifications
PIQUE, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does PIQUE, INC. have?
PIQUE, INC. has 13 U.S. trademarks filed with the USPTO. Of these, 12 registered, 1 abandoned.
What trademark classes does PIQUE, INC. file in?
PIQUE, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 30 (Staple Foods), Class 32 (Light Beverages), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are PIQUE, INC.'s most well-known trademarks?
PIQUE, INC.'s registered trademark portfolio includes well-known marks such as PIQUE, NANDAKA, LA GINGER, B· T FOUNTAIN, and DAILY RADIANCE. These are among 12 currently registered trademarks in the portfolio.
What is PIQUE, INC.'s trademark registration success rate?
PIQUE, INC. has a 92% trademark registration rate, with 12 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.